Oxybutynin Extended-Release Tablets and Siltuximab Intravenous
Determining the interaction of Oxybutynin Extended-Release Tablets and Siltuximab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: oxybutynin
Brand name: Ditropan XL, Anturol, Gelnique, Oxytrol
Synonyms: Oxybutynin
Generic Name: siltuximab
Brand name: Sylvant
Synonyms: Siltuximab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Oxybutynin Extended-Release Tablets-Silvadene
- Oxybutynin Extended-Release Tablets-Silvadene Topical
- Oxybutynin Extended-Release Tablets-SilvaSorb
- Oxybutynin Extended-Release Tablets-Silver
- Oxybutynin Extended-Release Tablets-Silver Nitrate
- Oxybutynin Extended-Release Tablets-Silver Nitrate Applicators
- Siltuximab Intravenous-Oxybutynin Gel
- Siltuximab Intravenous-Oxybutynin Oral Solution
- Siltuximab Intravenous-Oxybutynin Syrup
- Siltuximab Intravenous-Oxybutynin Tablets
- Siltuximab Intravenous-Oxybutynin transdermal
- Siltuximab Intravenous-Oxybutynin Transdermal System